Loading people...
Andrew Hedin is a Partner at Bessemer Venture Partners based in Cambridge, Massachusetts, where he leads investments across the healthcare and life sciences sectors. Before joining his current firm, he worked in venture capital at F-Prime Capital focusing on early-stage biotech and digital health, and served as a biopharma advisor. Hedin earned a Master of Business Administration from Harvard Business School, holds an undergraduate degree in healthcare management, and was recognized on the Forbes 30 Under 30 Venture Capital list in 2020. His investment portfolio features prominent healthcare startups including Hinge Health and Kymera Therapeutics, where he co-led a Series B funding round in 2018 prior to its 2020 initial public offering. Hedin currently focuses on backing early-stage and growth-stage companies that are developing new biotech therapeutics, healthcare software, and tech-enabled medical services across the broader healthcare ecosystem.
Andrew Hedin stands as a distinguished Partner at Bessemer Venture Partners, a globally recognized venture capital firm with a rich history of backing groundbreaking technology companies. Based in Bessemer's San Francisco office, Andrew plays a pivotal role in shaping the firm's investment strategy, particularly within the dynamic sectors of enterprise software, artificial intelligence (AI), and developer tools. His expertise extends to various facets of cloud infrastructure, SaaS, and data platforms, where he actively seeks out visionary founders and disruptive technologies.
Since joining Bessemer in 2014, Andrew has been instrumental in identifying and nurturing high-growth companies that redefine their respective industries. His investment philosophy centers on partnering with entrepreneurs who are building foundational technologies that drive efficiency, innovation, and competitive advantage for businesses worldwide. Andrew's keen eye for market trends and his deep understanding of technological advancements allow him to pinpoint opportunities that promise significant long term impact.
Among his notable investments, Andrew has supported companies that have become leaders in their fields. These include Hyperscience, an intelligent automation platform; Vanta, a security and compliance automation solution; Dataiku, a leading AI and machine learning platform; and Pinecone, a vector database for AI applications. He has also been involved with successful ventures like Pendo, a product experience platform; Zapier, an automation tool; and LaunchDarkly, a feature management platform. These investments underscore his commitment to backing companies that provide critical infrastructure and tools for the modern enterprise.
Before his tenure at Bessemer, Andrew honed his financial acumen and industry insights at Goldman Sachs, where he worked in technology investment banking. This experience provided him with a robust foundation in financial analysis, strategic advisory, and the intricacies of the technology market. Andrew is an alumnus of Princeton University, where he earned his degree, further solidifying his analytical capabilities and intellectual rigor. His comprehensive background, combining deep financial expertise with a passion for technological innovation, positions him as a trusted advisor and strategic partner to the entrepreneurs he supports. Andrew Hedin continues to drive Bessemer's mission of backing the next generation of enterprise technology leaders.
Andrew Hedin is a Partner at Bessemer Venture Partners, a prominent venture capital firm. He is an experienced investor focused on enterprise software, artificial intelligence, and developer tools.
Andrew Hedin primarily invests in companies developing enterprise software, artificial intelligence (AI) solutions, developer tools, cloud infrastructure, and SaaS platforms.
Andrew Hedin works as a Partner at Bessemer Venture Partners, a leading global venture capital firm.
